共 382 条
- [21] Shir K(2018)Effects of atorvastatin on portal hemodynamics and clinical outcomes in patients with cirrhosis with portal hypertension: a proof-of-concept study Eur J Gastroenterol Hepatol 30 1521-25.e3
- [22] Klein S(2017)Statin use and risk of cirrhosis and related complications in patients with chronic liver diseases: a systematic review and meta-analysis Clin Gastroenterol Hepatol 15 1495-692
- [23] Granzow M(2017)Beneficial effects of statins on the rates of hepatic fibrosis, hepatic decompensation, and mortality in chronic liver disease: a systematic review and meta-analysis Am J Gastroenterol 112 1498-580
- [24] Kureishi Y(2018)A risk score to predict the development of hepatic encephalopathy in a population-based cohort of patients with cirrhosis Hepatology 68 109096-623
- [25] Luo Z(2021)Statins and the risks of decompensated liver cirrhosis and hepatocellular carcinoma determined in patients with alcohol use disorder Drug Alcohol Depend 228 611-2269
- [26] Shiojima I(2013)Statin use and infections in veterans with cirrhosis Aliment Pharmacol Ther 38 1227-373
- [27] Bialik A(2021)Statin therapy in chronic viral hepatitis: a systematic review and meta-analysis of nine studies with 195,602 participants Ann Med 53 e0215839-91
- [28] Fulton D(2019)Statin use in cirrhotic patients with infectious diseases: a population-based study PLoS ONE 14 e1801-38
- [29] Lefer DJ(2015)Statin-based palliative therapy for hepatocellular carcinoma Medicine (Baltimore) 94 2117-522
- [30] Abraldes JG(2019)Statin use after diagnosis of hepatocellular carcinoma is associated with decreased mortality Clin Gastroenterol Hepatol 17 686-104